A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction

Table 4

Association between EFNA1 expression and the clinicopathological parameters of cervical cancer patients.

Clinicopathological parameters		Low expression	High expression	value
Age	<50 years	88	92	0.543
	>50 years	64	58
HPV status	Negative	7	2	0.171
	Positive	82	87
Histology	Adenocarcinoma	15	16	0.331
	Adenosquamous	3	0
	Squamous	71	73
Stage	I-II	70	71	0.730
	III-IV	18	16
Lymph node metastasis	Positive	18	15	0.738
	Negative	45	43